scholarly journals A Canadian perception of the nursing practice, research, and theoretical implications associated with Autologous Cell Transplantation

2021 ◽  
Author(s):  
Suzanne Fredericks ◽  
Monica Da Silva
Keyword(s):  
Heart Failure ◽  
Cell Transplantation ◽  
Nursing Practice ◽  
Severe Heart Failure ◽  
The United States ◽  
Practice Research ◽  
Innovative Therapy ◽  
Autologous Cell ◽  
Injured Myocardium ◽  
Autologous Cell Transplantation

Heart failure is a progressive disorder. An estimated 400,000 Canadians are diagnosed annually with heart failure, and a quarter experience severe heart failure that is unresponsive to medical therapy. Autologous cell transplantation (ACT) has been proposed as a new approach for cardiac repair, and holds enormous potential for the regeneration of injured myocardium cells. Currently, ACT is under investigation in Canada. The use of ACT as a treatment alternative for heart failure patients has been established over the past 5 years across Europe and the United States. This paper will present a Canadian perception of the nursing practice, research, and theoretical implications associated with this new and innovative therapy.

scholarly journals A Canadian perception of the nursing practice, research, and theoretical implications associated with Autologous Cell Transplantation

2021 ◽  
Author(s):  
Suzanne Fredericks
Keyword(s):  
Heart Failure ◽  
Cell Transplantation ◽  
Nursing Practice ◽  
Severe Heart Failure ◽  
The United States ◽  
Practice Research ◽  
Innovative Therapy ◽  
Autologous Cell ◽  
Injured Myocardium ◽  
Autologous Cell Transplantation

Heart failure is a progressive disorder. An estimated 400,000 Canadians are diagnosed annually with heart failure, and a quarter experience severe heart failure that is unresponsive to medical therapy. Autologous cell transplantation (ACT) has been proposed as a new approach for cardiac repair, and holds enormous potential for the regeneration of injured myocardium cells. Currently, ACT is under investigation in Canada. The use of ACT as a treatment alternative for heart failure patients has been established over the past 5 years across Europe and the United States. This paper will present a Canadian perception of the nursing practice, research, and theoretical implications associated with this new and innovative therapy.

scholarly journals A Canadian perception of the nursing practice, research, and theoretical implications associated with Autologous Cell Transplantation

2021 ◽  
Author(s):  
Suzanne Fredericks
Keyword(s):  
Heart Failure ◽  
Cell Transplantation ◽  
Nursing Practice ◽  
Severe Heart Failure ◽  
The United States ◽  
Practice Research ◽  
Innovative Therapy ◽  
Autologous Cell ◽  
Injured Myocardium ◽  
Autologous Cell Transplantation

Heart failure is a progressive disorder. An estimated 400,000 Canadians are diagnosed annually with heart failure, and a quarter experience severe heart failure that is unresponsive to medical therapy. Autologous cell transplantation (ACT) has been proposed as a new approach for cardiac repair, and holds enormous potential for the regeneration of injured myocardium cells. Currently, ACT is under investigation in Canada. The use of ACT as a treatment alternative for heart failure patients has been established over the past 5 years across Europe and the United States. This paper will present a Canadian perception of the nursing practice, research, and theoretical implications associated with this new and innovative therapy.

Abstract 5921: Medicare Beneficiaries with Mild to Severe Heart Failure See 15–23 Different Providers Annually

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Robert L Page ◽  
Christopher Hogan ◽  
Kara Strongin ◽  
Roger Mills ◽  
JoAnn Lindenfeld
Keyword(s):  
Heart Failure ◽  
Severe Heart Failure ◽  
The United States ◽  
Outpatient Setting ◽  
Fiscal Year ◽  
Hospital Inpatient ◽  
Medicare Beneficiaries ◽  
Improvement Program ◽  
Data Set ◽  
Mild Disease

In fiscal year 2003, Medicare beneficiaries with heart failure (HF) accounted for 37% of all Medicare spending and nearly 50% of all hospital inpatient costs. On average, each beneficiary had 10.3 outpatient and 2 inpatient visits specifically for HF. Despite significant improvements in medical care for HF, mortality and hospital admissions remain high. No data exist regarding the number of providers ordering and providing care for this population. An analysis of fiscal year 2005 Medicare claims was conducted, using a 5% sample standard analytic and denominator file, limited data set version to extrapolate the 34,150,200 Medicare beneficiaries. Three cohorts were defined according to mild, moderate, severe HF employing the Centers for Medicare and Medicaid Services Hierarchical Condition Categories Model and Chronic Care Improvement Program definitions. HMO enrollees, persons without Part A and Part B coverage, and those outside the United States were excluded. We identified physicians by using the unique physician identification number of performing physicians. Based on inclusion criteria, 173,863 beneficiaries were identified. The average number of providers providing care in all sites were 15.9, 18.6, 23.1 for beneficiaries with mild, moderate, and severe HF, respectively; and 10.1, 11.5, and 12.1 in the outpatient setting, respectively. The average number of providers ordering care in all sites consisted of 8.3, 9.6, and 11.2 for beneficiaries with mild, moderate, and severe HF, respectively; and 6.5,7.3, and 7.8 in the outpatient setting, respectively. For beneficiaries with mild disease, only 10% of all office visits were specifically for HF, while those with moderate or severe disease, only 20% were specifically for HF. Medicare beneficiaries with HF, even those with mild disease, have a large number of providers ordering and providing care. These data highlight the importance for developing systems and processes of coordinated care for this population.

Autologous cell transplantation for the treatment of damaged myocardium

2002 ◽  
Vol 45 (1) ◽  
pp. 21-32 ◽  
Author(s):  
Marc S. Penn ◽  
Gary S. Francis ◽  
Stephen G. Ellis ◽  
James B. Young ◽  
Patrick M. McCarthy ◽  
...  
Keyword(s):  
Cell Transplantation ◽  
Autologous Cell ◽  
Autologous Cell Transplantation
Sign in / Sign up

Export Citation Format

Share Document